Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients

(1) Background: Precision oncology is opening new treatment opportunities for patients suffering from solid tumors. In the last two decades, the advent of CDK4/6 inhibitors, immunotherapy, and antibody–drug conjugates (ADC) improved survival outcomes for advanced or metastatic breast cancers (BC). N...

Full description

Bibliographic Details
Main Authors:	Rosa Falcone, Pasquale Lombardi, Marco Filetti, Alessandra Fabi, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Current Oncology
Subjects:	next-generation sequencing breast cancer targeted therapy genomic
Online Access:	https://www.mdpi.com/1718-7729/30/2/191

Similar Items

Clinical and mutational profile of AT-rich interaction domain 1A-mutated cancers
by: Rosa Falcone, et al.
Published: (2023-08-01)

Comparing efficacy and safety of upfront treatment strategies for anaplastic lymphoma kinase-positive non-small cell lung cancer: a network meta-analysis
by: Marco Filetti, et al.
Published: (2023-12-01)

Novel applications of next-generation sequencing in breast cancer research
by: Rong Ma, et al.
Published: (2017-09-01)

Genomic characterization reveals distinct mutational landscapes and therapeutic implications between different molecular subtypes of triple-negative breast cancer
by: Ruo Qi Li, et al.
Published: (2024-05-01)

Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
by: Xuerui Li, et al.
Published: (2020-07-01)

Decoding mutational signatures in breast cancer: Insights from a multi-cohort study
by: Margaux Betz, et al.
Published: (2025-03-01)

Targeted next generation sequencing identifies somatic mutations in a cohort of Egyptian breast cancer patients
by: Auhood Nassar, et al.
Published: (2020-07-01)

Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses
by: Caterina Fumagalli, et al.
Published: (2020-10-01)

Molecular oncology update: Breast cancer gene expression profiling
by: Amit Verma, et al.
Published: (2015-07-01)

Targeted Next-Generation Sequencing of Circulating Tumor DNA Mutations among Metastatic Breast Cancer Patients
by: Min-Ying Sun, et al.
Published: (2021-06-01)

Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments
by: Mirai Ido, et al.
Published: (2024-01-01)

Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment‐naïve breast cancer
by: Shang‐Hung Chen, et al.
Published: (2024-06-01)

Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analyses
by: Chi-Cheng Huang, et al.
Published: (2021-02-01)

Personalized treatment in breast cancer
by: Min Kyoon Kim, et al.
Published: (2013-06-01)

Comprehensive bioinformatics analysis of selected germline variants of uncertain significance identified in a cohort of Sri Lankan hereditary breast cancer patients
by: Nipuni D. S. Arachchige, et al.
Published: (2025-02-01)

Molecular alterations and prognosis of breast cancer with cutaneous metastasis
by: Yan Xu, et al.
Published: (2024-07-01)

Association of Body Mass Index With Somatic Mutations in Breast Cancer
by: Bo Chen, et al.
Published: (2021-04-01)

MAMMARY-TYPE MYOFIBROBLASTOMAS: A REPORT ON FOUR CASES WITH EMPHASIS ON MOLECULAR PROFILING AND LITERATURE REVIEW
by: Anca EVSEI, et al.
Published: (2020-03-01)

Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesions
by: Toshiaki Akahane, et al.
Published: (2020-10-01)

EZH2 mutation is associated with the development of visceral metastasis by enhancing proliferation and invasion and inhibiting apoptosis in breast cancer cells
by: Fan Wu, et al.
Published: (2024-09-01)

Feasibility and Acceptability of a Newborn Screening Program Using Targeted Next-Generation Sequencing in One Maternity Hospital in Southern Belgium
by: Tamara Dangouloff, et al.
Published: (2024-07-01)

Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer
by: Diana N. Ionescu, et al.
Published: (2022-07-01)

From haystack to high precision: advanced sequencing methods to unraveling circulating tumor DNA mutations
by: Tamires Ferreira da Silva, et al.
Published: (2024-08-01)

Mapping breast and prostate cancer in the Brazilian public health system: study protocol of the Onco-Genomas Brasil
by: Jaqueline Bohrer Schuch, et al.
Published: (2024-03-01)

Genomics of Trypanosomatidae: Where We Stand and What Needs to Be Done?
by: Vyacheslav Yurchenko, et al.
Published: (2021-09-01)

The Clinically Actionable Molecular Profile of Early versus Late-Stage Non-Small Cell Lung Cancer, an Individual Age and Sex Propensity-Matched Pair Analysis
by: Anna L. McGuire, et al.
Published: (2022-04-01)

Profiling Receptor Tyrosine Kinase Fusions in Chinese Breast Cancers
by: Zhonghua Tao, et al.
Published: (2021-09-01)

Precision Medicine in Osteosarcoma: MATCH Trial and Beyond
by: Elisa Tirtei, et al.
Published: (2021-01-01)

Short Read Alignment Based on Maximal Approximate Match Seeds
by: Wei Quan, et al.
Published: (2020-11-01)

Evaluating somatic tumor mutation detection without matched normal samples
by: Jamie K. Teer, et al.
Published: (2017-09-01)

Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real‐world clinical tumor sequencing study
by: Yongsheng Huang, et al.
Published: (2024-03-01)

Early-onset breast cancer in a woman with a germline mobile element insertion resulting in BRCA2 disruption : a case report
by: Deuitch, Natalie, et al.
Published: (2020)

Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations
by: Matteo Allegretti, et al.
Published: (2018-03-01)

Comparing the diagnostic value of targeted with metagenomic next-generation sequencing in immunocompromised patients with lower respiratory tract infection
by: Muyun Wei, et al.
Published: (2024-09-01)

Acute Pulmonary Actinomycosis Induced by Immunotherapy and Chemotherapy Used for SCLC Treatment: A Case Report and Literature Review
by: Kuang J, et al.
Published: (2023-12-01)

Expanding the search for germline pathogenic variants for breast cancer. How far should we go and how high should we jump? The missed opportunity!
by: Hikmat Abdel-Razeq
Published: (2021-06-01)

From Conventional to Next Generation Sequencing of Epstein-Barr Virus Genomes
by: Hin Kwok, et al.
Published: (2016-02-01)

Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience
by: Lianna J. Marks, et al.
Published: (2017-12-01)

Targeted Next Generation Sequencing for malaria research in Africa: current status and outlook
by: Anita Ghansah, et al.
Published: (2019-09-01)

Landscape of circulating tumour DNA in metastatic breast cancer
by: Andrew A. Davis, et al.
Published: (2020-08-01)